FDA Officials Outline Initiatives to Improve Excipient Quality and Urge Manufacturers to Better Control Ingredient Variability
This article was originally published in The Gold Sheet
Executive Summary
FDA officials recently discussed the challenges of controlling excipient quality in an increasingly global environment and announced several initiatives they are taking to monitor the pharmaceutical supply chain.